Jiujiang University   Report issue

Academic/Hospital Phase 1 Phase 3
Founded: Jiujiang China (1901)

Organization Overview

First Clinical Trial
2020
NCT04270461
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Affiliated hospital of jiujiang university | Jiujiang University Affiliated Hospital

Active Ingredients

Drugs in Phase 3 Trials (1)

alteplase (Activase) (1 trial)

Drugs in Phase 1 Trials (1)

nkg2d car-t cell (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Hepatocellular (Phase 1)

Glioblastoma (Phase 1)

Medulloblastoma (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2